Danaher Acquires Masimo
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
The deal adds inspection, calibration, and repair services for outpatient and clinical settings as demand for reliable equipment support grows.
The deal brings a long-standing technetium Tc-99m generator operation and SPECT radiopharmaceutical portfolio into SHINE’s nuclear medicine platform.
Masimo will operate as a stand-alone business within the Danaher diagnostics segment, focusing on patient monitoring and pulse oximetry.
The executive hire will focus on bringing newly integrated global manufacturing and development capabilities to medical device companies.
Read MoreThe partnership includes an augmented service delivery model that includes service experts and field engineers to help support preventative maintenance for connected equipment to reduce downtime and complexity.
Read MoreThe new entity combines capabilities in system design, microelectronics, precision molding, and advanced manufacturing for medical device OEMs.
Read MoreThe new COO is responsible for advancing the company’s portfolio of tech-enabled solutions designed to improve asset uptime, reduce costs, and strengthen the capacity and efficiency of provider operations.
Read MoreThe move offers hospitals a new procurement and deployment channel for SaaS-based imaging software designed to improve workflow and data access.
Read MoreThe clinical asset management company ranked No 45 on the list, recognized for its company culture and employee experience.
Read More
The eight-year agreement aims to improve patient access and clinical productivity with advanced, multi-modality imaging equipment.